AssureRx Health Closes $12.5M Series C Financing

Published On May 31, 2012 |

AssureRx Health, Inc., a Mason, Ohio-based personalized medicine company, closed a $12.5m Series C financing.

The round was led by Four Rivers Group and existing investors Claremont Creek Ventures and Sequoia Capital, with participation from existing investors Cincinnati Children’s Hospital Medical Center, Mayo Clinic, CincyTech, Allos Ventures, as well as new investors jVen Capital and Alafi Capital.

Led by president and CEO James S. Burns, AssureRx Health provides clinically-relevant information to help physicians select the right drug for individual neuropsychiatric patients. The company intends to use the funding to increase commercial activities for its two flagship pharmacogenomic products, GeneSightRx® Psychotropic and GeneSightRx® ADHD, as well as next generation product development activities.



Like this Article? Share it!

Leave a Reply